Ecco renal - Study guides, Class notes & Summaries

ECCO Renal

ECCO Caring for Patients with Renal Disorders: Part 1 UPDATED Questions and CORRECT Answers A patient is receiving IV calcium gluconate, IV insulin, IV D50, and oral polystyrene sulfonate (Kayexalate). What evidence of the treatment's effectiveness should the nurse assess for? - CORRECT ANSWER- Decreased K levels Narrowed QRS Normalizing T waves Resolution of life-threatening hyperkalemia is assessed by monitoring the ECG rhythm for stability with resolution of widened QRS (we w...

ECCO part 2 questions with correct answers rated A+ 2023 Hypertensive crisis s/s - correct answer fatigue, malaise, weakness, and epistaxis chest pain, dyspnea, S3/4 heart sounds, pulmonary edema, HTN, increased HR, RR, and glucose CNS- headache, confusion, lethargy, coma, focal neurologic deficits, TIA, Encephalopathy renal- AKI, hematuria retinas- papilledema, blurred vision, retinal hemorrhage Which 4 s/s indicate that Mr. Hendrick is in hypertensive crisis? - correct answer L...

AACN ECCO Renal 2 Exam with Questions And Real Answers ...

ECCO Caring for Patients with Renal Disorders: Part 1 Questions With Complete Solutions

ECCO Caring for Patients with Renal Disorders: Part 1 | Questions and Correct Answers | Latest Update 2024/2025 A patient is receiving IV calcium gluconate, IV insulin, IV D50, and oral polystyrene sulfonate (Kayexalate). What evidence of the treatment's effectiveness should the nurse assess for? - Answer -Resolution of lifethreatening hyperkalemia is assessed by monitoring the ECG rhythm for stability with resolution of widened QRS, IVC delay, and peaked T waves; and assessing for decr...

ECCO CARING FOR PATIENTS WITH RENAL DISORDERS: PART 1 ACTUAL QUESTIONS AND ANSWERS 2024 SOLVED 100% A patient is receiving IV calcium gluconate, IV insulin, IV D50, and oral polystyrene sulfonate (Kayexalate). What evidence of the treatment's effectiveness should the nurse assess for? Ans- Resolution of life-threatening hyperkalemia is assessed by monitoring the ECG rhythm for stability with resolution of widened QRS, IVC delay, and peaked T waves; and assessing for decreasing K levels. ...

ECCO Caring for Patients with Renal Disorders: Part 1 | Questions and Correct Answers | Latest Update 2024/2025 A patient is receiving IV calcium gluconate, IV insulin, IV D50, and oral polystyrene sulfonate (Kayexalate). What evidence of the treatment's effectiveness should the nurse assess for? - Answer -Resolution of lifethreatening hyperkalemia is assessed by monitoring the ECG rhythm for stability with resolution of widened QRS, IVC delay, and peaked T waves; and assessing for de...

ECCO Caring for Patients with Renal Disorders; Part 1 2023-2024...

ECCO Caring for Patients with Renal Disorders: Part 2 (2023/2024) Graded A A patient with sepsis is receiving CRRT. The patient's serum lactate has increased from 4.1 (H) to 6.2 (H) in the past 24 hours. Which action should the nurse anticipate? Changing to a bicarbonate-based replacement solution A nurse is preparing to initiate vasopressor therapy in a patient who is undergoing CRRT with BP 86/45 (59) and HR 120 sinus tachycardia. What step should the nurse take before beginning the therapy...